Yang Qiu

Yang Qiu has over 20 years of MNC drug discovery and development experience with demonstrated success of leading drug discovery, translational medicine and early clinical development programs. Contributed to the discovery and progression into clinic of over 15 drug candidates and drug approvals including the most recent FDA BTD Patritumab Deruxtecan (HER3-DXd).